FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer By Ogkologos - January 29, 2026 131 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the TRITON3 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma 2026 ESMO Breast Cancer Award Recipient Announced Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type MOST POPULAR European Lung Cancer Congress 2025, Paris, France, 26-29 March 2025 March 20, 2025 “Mi corazón siempre dolerá”: Cómo honro a mi mejor amiga de... April 26, 2022 Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers May 2, 2018 Safety of Antibiotics in the Context of First-Line Chemo-Immunotherapy for Advanced... August 18, 2021 Load more HOT NEWS Online Retailer Chastised for Claiming Their Bra Reduces Risk of Breast... Fostering Growth and Creativity Through Journaling FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell... Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended...
